| Financial Year |
March 31 2022 |
| Monetary Funds |
902,315,717.97 |
| Held-for-trading Financial Assets |
3,000,367,695.52 |
| Notes Receivable |
1,950,000.00 |
| Accounts Receivable |
272,536,381.49 |
| Advances to Suppliers |
96,469,235.38 |
| Other Receivables |
74,071,254.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,450,401,054.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
471,285,665.90 |
| Total Current Assets |
16,782,428,058.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,359,980,510.97 |
| Investment Properties |
526,734,432.00 |
| Fixed Assetes |
194,765,993.43 |
| Under-construction Projects |
733,131.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,625,188.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,420,659.86 |
| Deferred Income Tax Assets |
192,201,740.49 |
| Other Non-Current Assets |
363,187,403.07 |
| Sub-Total of Non-Current Assets |
17,135,821,030.43 |
| Total Assets |
33,918,249,089.26 |
| Short-Term Loans |
3,294,935,972.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,600,000.00 |
| Accounts Payable |
2,587,452,516.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
278,250,439.40 |
| Taxes Payable |
1,346,316,894.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
217,395,746.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
453,561,229.38 |
| Other Current Liabilities |
1,661,296,438.24 |
| Sub-Total of Current Liabilities |
15,577,263,638.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,679,183,071.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,739,129,854.25 |
| Total Liabilities |
17,316,393,492.89 |
| Paid-In Capital(Or Share Stock) |
1,235,956,888.00 |
| Capital Surplus |
122,918,165.85 |
| Surplus Reserve |
1,605,619,269.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,699,083,155.89 |
| Minority Stockholder's Interest |
916,552,075.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,685,303,521.29 |
| Owner's Equity（Stockholder's Equity） |
16,601,855,596.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
33,918,249,089.26 |
